A randomised multicentre phase II study with cisplatin|[sol]|docetaxel vs oxaliplatin|[sol]|docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer

A Atmaca; S-E Al-Batran; D Werner; C Pauligk; T Güner; A Koepke; H Bernhard; T Wenzel; A-G Banat; P Brueck; K Caca; N Prasnikar; F Kullmann; H Günther Derigs; M Koenigsmann; G Dingeldein; T Neuhaus; E J?ger

首页> 外文期刊>British Journal of Cancer >A randomised multicentre phase II study with cisplatin|[sol]|docetaxel vs oxaliplatin|[sol]|docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer

【24h】

A randomised multicentre phase II study with cisplatin|[sol]|docetaxel vs oxaliplatin|[sol]|docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer

机译：多中心II期随机研究以顺铂| [sol] |多西他赛与奥沙利铂| [sol] |多西他赛为晚期或转移性非小细胞肺癌患者的一线治疗

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:This study was designed to compare cisplatin/docetaxel with oxaliplatin/docetaxel in patients with advanced and metastatic non-small lung cancer as a first-line treatment.

机译：背景：本研究旨在将顺铂/多西他赛与奥沙利铂/多西他赛作为一线治疗的晚期和转移性非小细胞肺癌患者进行比较。

著录项

来源
《British Journal of Cancer》 |2013年第2期|共6页
作者
A Atmaca; S-E Al-Batran; D Werner; C Pauligk; T Güner; A Koepke; H Bernhard; T Wenzel; A-G Banat; P Brueck; K Caca; N Prasnikar; F Kullmann; H Günther Derigs; M Koenigsmann; G Dingeldein; T Neuhaus; E J?ger;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Randomised phase II study of docetaxel|[sol]|cisplatin vs docetaxel|[sol]|irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803) [J] . N Yamamoto, M Fukuoka, S-I Negoro, British Journal of Cancer . 2004,第1期

机译：多西他赛| [sol] |顺铂与多西他赛| [sol] |伊立替康在晚期非小细胞肺癌中的随机II期研究：西日本胸腔肿瘤小组研究（WJTOG9803）
2. Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-small cell lung cancer: A multicenter randomized phase II trial of the Hellenic Oncology Research Group (HORG) [J] . Kotsakis A., Kentepozidis N., Emmanouilidis Ch., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2015,第1期

机译：相较于多西他赛加顺铂和贝伐单抗方案，长春瑞滨加顺铂和贝伐单抗，多西他赛加吉西他滨和贝伐单抗的序贯给药作为晚期或转移性非鳞状非小细胞肺癌一线治疗的多西他赛方案希腊肿瘤研究小组（HORG）
3. Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial [J] . D. Binder, H. Schweisfurth, C. Grah, Cancer Chemotherapy and Pharmacology . 2007,第1期

机译：多西他赛/吉西他滨或顺铂/吉西他滨再多西他赛在转移性非小细胞肺癌（NSCLC）患者的一线治疗中：一项多中心随机II期试验的结果
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012

机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
6. A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer [O] . A Atmaca, S-E Al-Batran, D Werner, 2013

机译：一项以顺铂/多西他赛与奥沙利铂/多西他赛为一线治疗的晚期或转移性非小细胞肺癌患者的多中心II期随机研究
7. Docetaxel maintenance therapy versus best supportive care after first-line chemotherapy with different dose docetaxel plus cisplatin for advanced non-small cell lung cancer (TFINE study, CTONG-0904): an open-label, randomized, phase III trial [O] . Li Zhang, Shun Lu, Ying Cheng, 2021

机译：多西紫杉醇维护治疗与不同剂量DOCETAXEL加顺铂的先进非小细胞肺癌（TFINE-0904）：开放标签，随机，第三阶段试验

A randomised multicentre phase II study with cisplatin|[sol]|docetaxel vs oxaliplatin|[sol]|docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer

摘要

著录项

相似文献

相关主题

期刊订阅